Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.
- Thorir D. Bjornsson, J. T. Callaghan, +19 authors S. Wrighton
- Business, Medicine
- Drug metabolism and disposition: the biological…
- 1 July 2003
Current regulatory guidances do not address specific study designs for in vitro and in vivo drug-drug interaction studies. There is a common desire by regulatory authorities and by industry sponsors… Expand
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
- J. A. Williams, B. Ring, +6 authors S. Wrighton
- Biology, Medicine
- Drug metabolism and disposition: the biological…
- 1 August 2002
The human cytochromes P450 (P450) CYP3A contribute to the biotransformation of 50% of oxidatively metabolized drugs. The predominant hepatic form is CYP3A4, but recent evidence indicates that CYP3A5… Expand
In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
- M. B. Fisher, K. Campanale, B. Ackermann, M. Vandenbranden, S. Wrighton
- Chemistry, Medicine
- Drug metabolism and disposition: the biological…
- 1 May 2000
The UDP-glucuronosyltransferases (UGTs) are a superfamily of membrane-bound enzymes whose active site is localized inside the endoplasmic reticulum. Glucuronidation using human liver microsomes has… Expand
Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression
- V. Lamba, J. Lamba, +8 authors E. Schuetz
- Biology, Medicine
- Journal of Pharmacology and Experimental…
- 1 December 2003
CYP2B6 metabolizes many drugs, and its expression varies greatly. CYP2B6 genotype-phenotype associations were determined using human livers that were biochemically phenotyped for CYP2B6 (mRNA,… Expand
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.
- J. Zhang, P. Kühl, +17 authors M. Boguski
- Biology, Medicine
- Pharmacogenetics
- 1 October 2001
The pregnane X receptor (PXR)/steroid and xenobiotic receptor (SXR) transcriptionally activates cytochrome P4503A4 (CYP3A4) when ligand activated by endobiotics and xenobiotics. We cloned the human… Expand
Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
- S. Wrighton, W. Brian, +5 authors M. Vandenbranden
- Biology, Medicine
- Molecular pharmacology
- 1 August 1990
The human P450III family has been shown to be composed of at least four members, P450IIIA3 (HLp), P450IIIA4 (P450NF), P450IIIA5 (HLp3), and P450IIIA6 (HLp2). Due to the lack of probes that… Expand
Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.
- J. C. Gorski, S. Hall, D. Jones, M. Vandenbranden, S. Wrighton
- Chemistry, Medicine
- Biochemical pharmacology
- 29 April 1994
The capabilities of cytochrome P4503A4 (CYP3A4), CYP3A5, and fetal hepatic microsomes containing CYP3A7 to metabolize midazolam were investigated using human hepatic microsomes and purified CYP3A4… Expand
Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation.
- S. Wrighton, J. C. Stevens, G. Becker, M. Vandenbranden
- Biology, Medicine
- Archives of biochemistry and biophysics
- 1 October 1993
In an effort to identify and characterize minor forms of human liver cytochrome P450, immunoblot analyses of microsome samples were developed with antibodies to various P450s that recognized multiple… Expand
The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†
- M. B. Fisher, M. Paine, T. J. Strelevitz, S. Wrighton
- Biology, Medicine
- Drug metabolism reviews
- 1 January 2001
At present, the methods and enzymology of the UDP-glucuronosyltransferases (UGTs) lag behind that of the cytochromes P450 (CYPs). About 15 human UGTs have been identified, and knowledge about their… Expand
Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- N. A. Farid, A. Kurihara, S. Wrighton
- Chemistry, Medicine
- Journal of clinical pharmacology
- 1 February 2010
Ticlopidine, clopidogrel, and prasugrel are thienopyridine prodrugs that inhibit adenosine‐5′‐diphosphate (ADP)‐mediated platelet aggregation in vivo. These compounds are converted to… Expand